Scientific Industries Inc Revenue Growth Rates (SCND), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Scientific Industries Inc   (SCND)
 

SCND's Revenue Growth by Quarter and Year

Scientific Industries Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCND Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.47
1st Quarter March 1.23
FY 2.70

SCNDs Annual Revenue
Scientific Industries Inc 's Revenue in the fiscal year 2025 $ 5.05 millions
Scientific Industries Inc 's Revenue in the fiscal year 2024 $ 10.71 millions
Scientific Industries Inc 's Revenue in the fiscal year 2023 $ 11.11 millions
Scientific Industries Inc 's Revenue in the fiscal year 2022 $ 11.40 millions
Scientific Industries Inc 's Revenue in the fiscal year 2020 $ 9.78 millions




SCND Revenue second quarter 2026 Y/Y Growth Comment
Scientific Industries Inc achieved in the second quarter 2026, above Company average Revenue growth of 36.15% year on year, to $ 1.47 millions.

Looking into second quarter 2026 results within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue growth. While Scientific Industries Inc ' s Revenue rise of 36.15% ranks overall at the positon no. 3417 in the second quarter 2026.


SCND Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -41.99 % 2.55 % 2.62 %
3rd Quarter September - 5.26 % -48.65 % -6.83 %
2nd Quarter June 36.15 % -59.25 % -11.07 % 4.2 %
1st Quarter March 30.85 % -62.1 % -11.74 % -3.1 %
FY   - -45.52 % -16.64 % -

Financial Statements
Scientific Industries Inc 's second quarter 2026 Revenue $ 1.47 millions SCND's Income Statement
Scientific Industries Inc 's second quarter 2025 Revenue $ 1.08 millions Quarterly SCND's Income Statement


SCND Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 16.43 % 111.28 % 5.79 %
3rd Quarter September - 29.63 % -49.81 % -13.09 %
2nd Quarter June 19.54 % 14.89 % 6.85 % 6.05 %
1st Quarter March -24.54 % -66.55 % -9.49 % 5.24 %
FY (Year on Year)   - -45.52 % -16.64 % -


Back to SCND Growth rate Comparisons >> Back to SCND Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #457
Overall #3417

Revenue Y/Y Growth Statistics
High Average Low
43.98 % -4.34 % -146.92 %
(Mar 31 2019)   (Mar 31 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #457
Overall #3417
Revenue Y/Y Growth Statistics
High Average Low
43.98 % -4.34 % -146.92 %
(Mar 31 2019)   (Mar 31 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Scientific Industries Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
165.82 % 1.98 % -100 %
(Jun 30 2016)  


SCND's II. Quarter Q/Q Revenue Comment
Scientific Industries Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 19.54%, to $ 1.47 millions, from $1.23 millions in the first quarter.
SCND is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Scientific Industries Inc 's Revenue growth quarter on quarter, overall rank is 523.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #101
Overall #523
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #101
Overall #523
Revenue Q/Q Growth Statistics
High Average Low
165.82 % 1.98 % -100 %
(Jun 30 2016)  


SCND's II. Quarter Q/Q Revenue Comment
Scientific Industries Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 19.54%, to $ 1.47 millions, from $1.23 millions in the first quarter.
SCND is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Scientific Industries Inc 's Revenue growth quarter on quarter, overall rank is 523.


Scientific Industries Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 5.73 $ 5.34 $ 5.05 $ 6.24 $ 6.17
Y / Y Revenue Growth (TTM) -7.17 % -30.99 % -45.53 % -32.2 % -40.98 %
Year on Year Revenue Growth Overall Ranking # 3597 # 2360 # 0 # 2541 # 2577
Seqeuential Revenue Change (TTM) 7.29 % 5.64 % -19.01 % 1.13 % -20.25 %
Seq. Revenue Growth (TTM) Overall Ranking # 3417 # 2299 # 0 # 2066 # 2323


Cumulative Revenue growth Comment
Scientific Industries Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Scientific Industries Inc 's annual Revenue fall would be -7.17% year on year to $6 millions.

In the Healthcare sector 488 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2360 to 3597.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 20
Healthcare Sector # 489
Overall # 3597

Revenue TTM Y/Y Growth Statistics
High Average Low
43.98 %
 -4.34 %
-146.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 457
S&P 500 # 3417
Cumulative Revenue growth Comment
Scientific Industries Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Scientific Industries Inc 's annual Revenue drop would be -7.17% year on year to $6 millions.

In the Healthcare sector 488 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2360 to 3597.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 20
Healthcare Sector # 489
Overall # 3597

Revenue TTM Y/Y Growth Statistics
High Average Low
43.98 %
-4.34 %
-146.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 457
S&P 500 # 3417




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SCND's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions
Edap Tms Sa38.85%$ 38.847 millions


About Scientific Industries Inc Revenue Growth Rates (SCND), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Scientific Industries Inc (CIK 87802).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001654954-26-007600
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Scientific Industries Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.